Literature DB >> 25784734

Onco-nephrology: current concepts and future perspectives.

Yuichiro Kitai1, Takeshi Matsubara1, Motoko Yanagita2.   

Abstract

Onco-nephrology is a new and evolving subspecialized area in nephrology that deals with kidney diseases in cancer patients. As many newer cancer therapies emerge in the field of oncology, cancer patients are surviving longer than ever before. However, the benefits of the remarkable advances in cancer management have not been fully appreciated. Not only is cancer often associated with abnormalities that affect the kidney, but cancer therapy often leads to both acute and chronic kidney diseases. The development of cancer-associated kidney complications is associated with poor prognosis, whereas prompt recognition and treatment initiation are associated with improved outcomes in this population. Therefore, both nephrologists and oncologists should be familiar with the diagnosis and management of cancer-associated kidney complications. Another unique aspect of onco-nephrology is that significant improvements in predialysis and dialysis care in recent years have led to prolonged survival and a higher incidence of patients with chronic kidney disease suffering from cancer. Therefore, research is urgently needed to establish treatment for patients with chronic kidney disease. This update addresses the pathophysiology and treatment of various cancer-associated kidney complications, and highlights cancer treatment for patients with chronic kidney disease.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cancer and the kidney; dialysis; onco-nephrology; therapeutic drug monitoring; thrombotic microangiopathy

Mesh:

Substances:

Year:  2015        PMID: 25784734     DOI: 10.1093/jjco/hyv035

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

1.  Association between chronic kidney disease and cancer including the mortality of cancer patients: national health and nutrition examination survey 1999-2014.

Authors:  Kanglin Guo; Zufeng Wang; Ran Luo; Yichun Cheng; Shuwang Ge; Gang Xu
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

Review 2.  Chronic Kidney Disease and Cancer: Inter-Relationships and Mechanisms.

Authors:  Mengsi Hu; Qianhui Wang; Bing Liu; Qiqi Ma; Tingwei Zhang; Tongtong Huang; Zhimei Lv; Rong Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-18

Review 3.  Role of Nigella sativa and Its Constituent Thymoquinone on Chemotherapy-Induced Nephrotoxicity: Evidences from Experimental Animal Studies.

Authors:  Marco Cascella; Giuseppe Palma; Antonio Barbieri; Sabrina Bimonte; Nagoth Joseph Amruthraj; Maria Rosaria Muzio; Vitale Del Vecchio; Domenica Rea; Michela Falco; Antonio Luciano; Claudio Arra; Arturo Cuomo
Journal:  Nutrients       Date:  2017-06-17       Impact factor: 5.717

4.  Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan.

Authors:  Taro Funakoshi; Takahiro Horimatsu; Michio Nakamura; Koichi Shiroshita; Koichi Suyama; Masashi Mukoyama; Takuro Mizukami; Tsutomu Sakurada; Eishi Baba; Kazuhiko Tsuruya; Akira Nozaki; Kensei Yahata; Yukinori Ozaki; Yoshifumi Ubara; Hisateru Yasui; Akihiro Yoshimoto; Shingo Fukuma; Naoya Kondo; Takeshi Matsubara; Kazuo Matsubara; Shunichi Fukuhara; Motoko Yanagita; Manabu Muto
Journal:  ESMO Open       Date:  2018-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.